| Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense … E Pasmant, I Laurendeau, D Héron, M Vidaud, D Vidaud, I Bieche Cancer research 67 (8), 3963-3969, 2007 | 751 | 2007 |
| ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS E Pasmant, A Sabbagh, M Vidaud, I Bièche The FASEB Journal 25 (2), 444-448, 2011 | 523 | 2011 |
| COVID-19: Discovery, diagnostics and drug development T Asselah, D Durantel, E Pasmant, G Lau, RF Schinazi Journal of hepatology 74 (1), 168-184, 2021 | 477 | 2021 |
| PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies T De Raedt, E Beert, E Pasmant, A Luscan, H Brems, N Ortonne, K Helin, ... Nature 514 (7521), 247-251, 2014 | 447 | 2014 |
| Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome C Nava, N Hanna, C Michot, S Pereira, N Pouvreau, T Niihori, Y Aoki, ... Journal of medical genetics 44 (12), 763-771, 2007 | 292 | 2007 |
| NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype E Pasmant, A Sabbagh, G Spurlock, I Laurendeau, E Grillo, MJ Hamel, ... Human mutation 31 (6), E1506-E1518, 2010 | 265 | 2010 |
| NF1 Molecular Characterization and Neurofibromatosis Type I Genotype–Phenotype Correlation: The French Experience A Sabbagh, E Pasmant, A Imbard, A Luscan, M Soares, H Blanché, ... Human mutation 34 (11), 1510-1518, 2013 | 187 | 2013 |
| Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1 A Sabbagh, E Pasmant, I Laurendeau, B Parfait, S Barbarot, B Guillot, ... Human molecular genetics 18 (15), 2768-2778, 2009 | 167 | 2009 |
| Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma N Burnichon, A Buffet, B Parfait, E Letouzé, I Laurendeau, C Loriot, ... Human molecular genetics 21 (26), 5397-5405, 2012 | 166 | 2012 |
| Neurofibromatosis type 1: from genotype to phenotype E Pasmant, M Vidaud, D Vidaud, P Wolkenstein Journal of medical genetics 49 (8), 483-489, 2012 | 165 | 2012 |
| RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action J Masliah-Planchon, S Garinet, E Pasmant Oncotarget 7 (25), 38892, 2016 | 162 | 2016 |
| Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1 E Pasmant, A Sabbagh, J Masliah-Planchon, N Ortonne, I Laurendeau, ... Journal of the National Cancer Institute 103 (22), 1713-1722, 2011 | 136 | 2011 |
| Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? E Pasmant, B Parfait, A Luscan, P Goussard, A Briand-Suleau, ... European Journal of Human Genetics 23 (5), 596-601, 2015 | 130 | 2015 |
| SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype E Pasmant, A Sabbagh, N Hanna, J Masliah-Planchon, E Jolly, ... Journal of medical genetics 46 (7), 425-430, 2009 | 120 | 2009 |
| BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation A Campagne, MK Lee, D Zielinski, A Michaud, S Le Corre, F Dingli, ... Nature communications 10 (1), 348, 2019 | 118 | 2019 |
| Mutations in SETD2 cause a novel overgrowth condition A Luscan, I Laurendeau, V Malan, C Francannet, S Odent, F Giuliano, ... Journal of medical genetics 51 (8), 512-517, 2014 | 114 | 2014 |
| Review and update of SPRED1 mutations causing legius syndrome H Brems, E Pasmant, R Van Minkelen, K Wimmer, M Upadhyaya, ... Human mutation 33 (11), 1538-1546, 2012 | 108 | 2012 |
| Expression of ANRIL–Polycomb Complexes–CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent … D Meseure, S Vacher, KD Alsibai, A Nicolas, W Chemlali, M Caly, ... Molecular cancer research 14 (7), 623-633, 2016 | 94 | 2016 |
| Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer D Meseure, S Vacher, F Lallemand, KD Alsibai, R Hatem, W Chemlali, ... British journal of cancer 114 (12), 1395-1404, 2016 | 92 | 2016 |
| Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis M Wassef, V Rodilla, A Teissandier, B Zeitouni, N Gruel, B Sadacca, ... Genes & development 29 (24), 2547-2562, 2015 | 88 | 2015 |
